Keyphrases
Systolic Heart Failure
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Perindopril
80%
Enalapril
80%
Trandolapril
80%
Ramipril
80%
Adjusted Hazard Ratio
60%
Subgroup Analysis
40%
All-cause Mortality
40%
Ejection Fraction
40%
No Significant Difference
40%
Heart Failure
40%
Registry-based
20%
Ischemic Heart Disease
20%
Agent Types
20%
Hospital Diagnosis
20%
Heart Failure with Preserved Ejection Fraction (HFpEF)
20%
New User
20%
Risk Score
20%
Class Effect
20%
Incidence Rate
20%
Heart Disease Diagnosis
20%
Patients with Heart Failure
20%
Medicine and Dentistry
ACE Inhibitor
100%
Systolic Heart Failure
100%
Trandolapril
80%
Perindopril
80%
Enalapril
80%
Hazard Ratio
60%
Congestive Heart Failure
60%
All Cause Mortality
40%
Ejection Fraction
40%
Subgroup Analysis
40%
Heart Failure with Reduced Ejection Fraction
20%
New York Heart Association Class
20%
Cohort Analysis
20%
Ischemic Heart Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Systolic Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Trandolapril
80%
Perindopril
80%
Ramipril
80%
Enalapril
80%
Congestive Heart Failure
60%
All Cause Mortality
40%
Ischemic Heart Disease
20%
Heart Failure with Reduced Ejection Fraction
20%
Cohort Study
20%